Latest news
Sea anemone flips a human antiviral strategy on its head
A new study has uncovered a previously unknown antiviral defense mechanism in sea anemones, revealing that animals may have evolved more than one way to fight viral infections.
New research makes critical discovery for the global fight against antibiotic resistance
A study has found that an unusual pairing of two commonly used antibiotics can kill and stop the spread of resistance in a highly drug-resistant bacterium, Pseudomonas aeruginosa.
Climate change could reshape flu seasons across the Americas
Researchers find that weather and climate patterns can help predict the timing and severity of flu outbreaks across diverse regions.
Gut microbiome could hold important clues as to how IBD develops and progresses
The gut microbiome could hold important clues as to how IBD develops and progresses – and which treatment is best suited to individual patients.
Global burden of viral skin diseases rises 36% since 1990: Children and elderly bear the brunt
Global analysis of viral skin diseases underscores the need for equitable policies: while high-income countries have made progress via vaccination and better healthcare, low-resource regions lag behind.
Rings of power – how bacteria use circadian clocks to colonise their world
A new study reveals how bacteria rely on circadian clocks to control the spread of their multi-cellular colonies.
Sea anemone flips a human antiviral strategy on its head
A new study has uncovered a previously unknown antiviral defense mechanism in sea anemones, revealing that animals may have evolved more than one way to fight viral infections.
New research makes critical discovery for the global fight against antibiotic resistance
A study has found that an unusual pairing of two commonly used antibiotics can kill and stop the spread of resistance in a highly drug-resistant bacterium, Pseudomonas aeruginosa.
Climate change could reshape flu seasons across the Americas
Researchers find that weather and climate patterns can help predict the timing and severity of flu outbreaks across diverse regions.
Bruke showcases expanding Microbiology & Infection Diagnostics portfolio at ASM Microbe 2026
At ASM Microbe 2026, Bruker Corporation’s Microbiology & Infection Diagnostics (BMID) division demonstrated its expanding portfolio and innovations across microbial identification, sepsis diagnostics, molecular testing, and NGS workflows, advancing clinical research, and faster, actionable infectious disease diagnostics.
Andelyn Biosciences launches LVV Curator® Platform
Andelyn Biosciences has announced the launch of its LVV Curator® Platform, a standardized lentiviral vector (LVV) manufacturing solution built on the same proven modular approach that supports clinical and commercial adeno-associated virus (AAV) programs.
Modular Clean Air strengthens position as part of Total Clean AIr
Modular Clean Air (MCA) is now wholly owned by Total Clean Air (TCA), marking the next phase in its development following its successful launch as a joint venture in 2025.
Black box: Using AI to tackle global superbug crisis
The development of new antibiotics could be sped up thanks to a new tool that tests the reliability of AI. Researchers designed a framework to address the global threat of antimicrobial resistance, testing whether AI can provide reliable reasoning during antibiotic development.
Algae microbots take aim at bladder cancer
Tiny algae-based robots guided by magnets could improve bladder cancer treatment by boosting delivery of chemotherapy drugs into tumours. Tracked using real-time imaging, the miniature robots help drugs penetrate deep into tumour tissue while limiting damage to healthy cells.
Biochar-coated catalyst turns wet microalgae into cleaner fuel-building chemicals
Turning microalgae into usable liquid fuels remains difficult because algae-derived bio-oil often contains high levels of oxygen and nitrogen compounds. A new study reports a promising strategy to address this challenge.
Gut microbiome could hold important clues as to how IBD develops and progresses
The gut microbiome could hold important clues as to how IBD develops and progresses – and which treatment is best suited to individual patients.
Free webinar: The mystery of the missing microbes - and the answers that can be found in the Amazon
An intriguing free webinar this July will explore what happens when key members of the human gut microbiome are lost, and what we can learn from populations where this loss has not occurred.
International Photodynamic Association highlights expansion of photodynamic therapy
The International Photodynamic Association (IPA) convened global leaders in photodynamic therapy (PDT) at the 8th Photodynamic Day, highlighting the continued development of PDT in Türkiye and its growing clinical relevance internationally.